However, despite the high prevalence of hypertension in the study group (64.4% of patients with carotid atherosclerosis), only 48.9% of patients took beta-blockers, 51.5% took angiotensin-converting enzyme inhibitors (ACE-inhibitors) or sartans, and 39.1% took calcium channel blockers. The gene discussed is ACE; the disease is carotid atherosclerosis.